2,835
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy

, , , , , , , , , , , & show all
Pages 1617-1630 | Received 05 Sep 2017, Accepted 10 Oct 2017, Published online: 24 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mahvash Hesari, Pantea Mohammadi, Fatemeh Khademi, Dareuosh Shackebaei, Saeideh Momtaz, Narges Moasefi, Mohammad Hosein Farzaei & Mohammad Abdollahi. (2021) Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases. International Journal of Nanomedicine 16, pages 3293-3315.
Read now
Xiaoming Zhou & Xiaoyan Xia. Ginsenoside Rg3 improves microcystin-induced cardiotoxicity through the miR-128-3p/MDM4 axis. Drug and Chemical Toxicology 0:0, pages 1-11.
Read now

Articles from other publishers (40)

Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone, Shin Ohta & Sadahiko Shimoeda. (2023) Red Ginseng Is a Therapeutic Candidate for Chronic Doxorubicin-Induced Cardiomyopathy in Mice. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-8.
Crossref
Yanmei Huang, Jing Lu, Laien Zhao, Xiaoxuan Fu, Shengjun Peng, Wen Zhang, Rong Wang, Wenze Yuan, Rongrui Luo, Xiaojie Wang, Zelin Li & Zhuhong Zhang. (2023) Retinal cell-targeted liposomal ginsenoside Rg3 attenuates retinal ischemia-reperfusion injury via alleviating oxidative stress and promoting microglia/macrophage M2 polarization. Free Radical Biology and Medicine 206, pages 162-179.
Crossref
Sri Renukadevi Balusamy, Haribalan Perumalsamy, Md. Amdadul Huq, Tae Hyun Yoon, Ivan Mijakovic, Lakshmi Thangavelu, Deok Chun Yang & Shadi Rahimi. (2023) A comprehensive and systemic review of ginseng‐based nanomaterials: Synthesis, targeted delivery, and biomedical applications. Medicinal Research Reviews 43:5, pages 1374-1410.
Crossref
Xuanming Luo. (2023) Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity. Environmental Research, pages 116989.
Crossref
Lan Li, Jiasong Cao, Sheng Li, Tianyi Cui, Jingyu Ni, Han Zhang, Yan Zhu, Jingyuan Mao, Xiumei Gao, Adam C. Midgley, Meifeng Zhu & Guanwei Fan. (2023) M2 Macrophage‐Derived sEV Regulate Pro‐Inflammatory CCR2 + Macrophage Subpopulations to Favor Post‐AMI Cardiac Repair . Advanced Science 10:14.
Crossref
Jie Wang, Yong-Mei Liu, Jun Hu & Cong Chen. (2023) Trained immunity in monocyte/macrophage: Novel mechanism of phytochemicals in the treatment of atherosclerotic cardiovascular disease. Frontiers in Pharmacology 14.
Crossref
Arezoo Moini Jazani, AmirAhmad Arabzadeh, Hamed Haghi-Aminjan & Ramin Nasimi Doost Azgomi. (2023) The role of ginseng derivatives against chemotherapy-induced cardiotoxicity: A systematic review of non-clinical studies. Frontiers in Cardiovascular Medicine 10.
Crossref
Ahmed Elfadadny, Rokaia F. Ragab, Rania Hamada, Soad K. Al Jaouni, Junjiang Fu, Shaker A. Mousa & Ali H. El-Far. (2023) Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety. Toxicology and Applied Pharmacology 461, pages 116405.
Crossref
Won Ho Jung, Jihyeon Song, Gayeon You, Jun Hyuk Lee, Sin Won Lee, Joong-Hoon Ahn & Hyejung Mok. (2022) Protection of Skin Fibroblasts from Infrared-A-Induced Photo-Damage Using Ginsenoside Rg3(S)-Incorporated Soybean Lecithin Liposomes. Journal of Microbiology and Biotechnology 33:1, pages 135-141.
Crossref
Shadi Rahimi, Daniel van Leeuwen, Fariba Roshanzamir, Santosh Pandit, Lei Shi, Nima Sasanian, Jens Nielsen, Elin K. Esbjörner & Ivan Mijakovic. (2023) Ginsenoside Rg3 Reduces the Toxicity of Graphene Oxide Used for pH-Responsive Delivery of Doxorubicin to Liver and Breast Cancer Cells. Pharmaceutics 15:2, pages 391.
Crossref
Xin Su, Xiaoyu Zhang, Wenjing Liu, Xinyu Yang, Na An, Fan Yang, Jiahao Sun, Yanwei Xing & Hongcai Shang. (2022) Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy. Seminars in Cancer Biology 86, pages 929-942.
Crossref
Shuting Zuo, Jing Wang, Xianquan An, Zhenyu Wang, Xiao Zheng & Yan Zhang. (2022) Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Yue Ke, Lei Huang, Yu Song, Zhenxin Liu, Linshuang Liang, Linmao Wang & Taoyun Wang. (2022) Preparation and pharmacological effects of minor ginsenoside nanoparticles: a review. Frontiers in Pharmacology 13.
Crossref
Pei-Rong Qu, Zhi-Lin Jiang, Ping-Ping Song, Lan-Chun Liu, Mi Xiang & Jie Wang. (2022) Saponins and their derivatives: Potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance. Pharmacological Research 182, pages 106352.
Crossref
Xiaoli Tang, Zengwu Wang, Shengshou Hu & Bingying Zhou. (2022) Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation. Pharmaceutics 14:7, pages 1313.
Crossref
Boyong Qiu, Meijiao Mao, Zilin Ma, Bing Deng, Lin Shen, Duan Zhou, Wang Zheng & Yihong Wei. (2022) Ginsenoside Rg2 Attenuates Doxorubicin-induced Cardiomyocyte Apoptosis via the PI3K/Akt Pathway. Revista Brasileira de Farmacognosia 32:3, pages 433-439.
Crossref
Jishuang Liu, Yu Xin, Zhidong Qiu, Qi Zhang, Tianzhu He, Ye Qiu & Weinan Wang. (2022) Cordyceps sinensis -mediated biotransformation of notoginsenoside R1 into 25-OH-20( S / R )-R2 with elevated cardioprotective effect against DOX-induced cell injury . RSC Advances 12:21, pages 12938-12946.
Crossref
Jingyu Ni, Zhihao Liu, Miaomiao Jiang, Lan Li, Jie Deng, Xiaodan Wang, Jing Su, Yan Zhu, Feng He, Jingyuan Mao, Xiumei Gao & Guanwei Fan. (2022) Ginsenoside Rg3 ameliorates myocardial glucose metabolism and insulin resistance via activating the AMPK signaling pathway. Journal of Ginseng Research 46:2, pages 235-247.
Crossref
Qianqian Zhang, Xuemei Li, Xiaoxin Gao, Chunran Cao, Yuchi Hu & Hongzhu Guo. (2021) Total saponins from stems and leaves of Panax quinquefolius L. ameliorate podophyllotoxin‐induced myelosuppression and gastrointestinal toxicity . Biomedical Chromatography 36:2.
Crossref
Shi-Yao Wan, Jin-Gui Hu, Yu Zhang, Bo-Yang Yu, Jun-Ping Kou & Fang Li. (2022) Recent advances of traditional chinese medicine in the regulation of myocardial mitochondrial function. World Journal of Traditional Chinese Medicine 8:1, pages 50.
Crossref
Fang Yang, Ming-Yue Yang, Jing-Qing Le, Bang-Yue Luo, Meng-Die Yin, Chao-Li, Jia-Li Jiang, Yi-Fan Fang & Jing-Wei Shao. (2022) Protective Effects and Therapeutics of Ginsenosides for Improving Endothelial Dysfunction: From Therapeutic Potentials, Pharmaceutical Developments to Clinical Trials. The American Journal of Chinese Medicine 50:03, pages 749-772.
Crossref
Yuan Lu, Jie Pan, Xiaoqing Zhu, Shuai Zhang, Chunhua Liu, Jia Sun, Yueting Li, Siying Chen, Jing Huang, Chuang Cao, Yonglin Wang, Yongjun Li & Ting Liu. (2021) Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma. BMC Pharmacology and Toxicology 22:1.
Crossref
Yan Wan, Jing Wang, Jin-feng Xu, Fei Tang, Lu Chen, Yu-zhu Tan, Chao-long Rao, Hui Ao & Cheng Peng. (2021) Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects. Journal of Ginseng Research 45:6, pages 617-630.
Crossref
Hong Wang, Yu Zheng, Qiang Sun, Zhen Zhang, Mengnan Zhao, Cheng Peng & Sanjun Shi. (2021) Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. Journal of Nanobiotechnology 19:1.
Crossref
Zhihao Liu, Xiyun Bian, Wenbo Gao, Jing Su, Chuanrui Ma, Xiaolin Xiao, Tian Yu, Han Zhang, Xiaozhi Liu & Guanwei Fan. (2021) Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure. Pharmacological Research 172, pages 105843.
Crossref
Xutao Sun, Yunjia Song, Ying Xie, Jieru Han, Fei Chen, Yang Sun, Bowen Sui & Deyou Jiang. (2021) Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-13.
Crossref
Yichuan Jiang, Dayun Sui, Xiaofeng Yu, Yaozhen Wang, Huali Xu & Li Fu. (2021) Ginsenoside Rg 3 Attenuates Early Hepatic Injury via Inhibiting PPARγ- and Ang II-Related Inflammation and Fibrosis in Type II Diabetic Mice . Natural Product Communications 16:4, pages 1934578X2110096.
Crossref
Michael Sarhene, Jing Yu Ni, Esi Sophia Duncan, Zhihao Liu, Sheng Li, Jing Zhang, Rui Guo, Shan Gao, Xiumei Gao & Guanwei Fan. (2021) Ginsenosides for cardiovascular diseases; update on pre-clinical and clinical evidence, pharmacological effects and the mechanisms of action. Pharmacological Research 166, pages 105481.
Crossref
Shan Gao, Lina Wang, Yu Zhang, Lan Li, Yunsha Zhang, Xiumei Gao, Jingyuan Mao, Lianyong Wang, Lichen Wang, Hongjun Wang, Meifeng Zhu & Guanwei Fan. (2020) Tanshinone IIA-loaded aligned microfibers facilitate stem cell recruitment and capillary formation by inducing M2 macrophage polarization. Applied Materials Today 21, pages 100841.
Crossref
Yi Yan, Chengyu Xiang, Zhijian Yang, Dengshun Miao & Dingguo Zhang. (2020) Rho Kinase Inhibition by Fasudil Attenuates Adriamycin-Induced Chronic Heart Injury. Cardiovascular Toxicology 20:4, pages 351-360.
Crossref
Xiaoping Wang, Hui Meng, Qixin Wang, Mingyan Shao, Wenji Lu, Xu Chen, Yong Jiang, Chun Li, Yong Wang & Pengfei Tu. (2020) Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats. Journal of Ethnopharmacology 252, pages 112536.
Crossref
Lan Li, Yili Wang, Rui Guo, Sheng Li, Jingyu Ni, Shan Gao, Xiumei Gao, Jingyuan Mao, Yan Zhu, Pingli Wu, Hongjun Wang, Deling Kong, Han Zhang, Meifeng Zhu & Guanwei Fan. (2020) Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury. Journal of Controlled Release 317, pages 259-272.
Crossref
Ricardo Lagoa, João Silva, Joaquim Rui Rodrigues & Anupam Bishayee. (2020) Advances in phytochemical delivery systems for improved anticancer activity. Biotechnology Advances 38, pages 107382.
Crossref
Hui Liu, Yichuan Jiang, Min Li, Xiaofeng Yu, Dayun Sui & Li Fu. (2019) Ginsenoside Rg3 Attenuates Angiotensin II-Mediated Renal Injury in Rats and Mice by Upregulating Angiotensin-Converting Enzyme 2 in the Renal Tissue. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-11.
Crossref
Qiaohong Qian, Wanqing Chen, Yajuan Cao, Qi Cao, Yajing Cui, Yan Li & Jianchun Wu. (2019) Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine. Oxidative Medicine and Cellular Longevity 2019, pages 1-23.
Crossref
Paulina Koczurkiewicz, Katarzyna Klaś, Karolina Grabowska, Kamil Piska, Katarzyna Rogowska, Katarzyna Wójcik‐Pszczoła, Irma Podolak, Agnieszka Galanty, Marta Michalik & Elżbieta Pękala. (2019) Saponins as chemosensitizing substances that improve effectiveness and selectivity of anticancer drug—Minireview of in vitro studies. Phytotherapy Research 33:9, pages 2141-2151.
Crossref
Congcong Xu, Weiwei Wang, Bing Wang, Tong Zhang, Xiuming Cui, Yiqiong Pu & Ning Li. (2019) Analytical methods and biological activities of Panax notoginseng saponins: Recent trends. Journal of Ethnopharmacology 236, pages 443-465.
Crossref
Yue Gu, Aichun Ju, Bingjie Jiang, Jingze Zhang, Shuli Man, Changxiao Liu & Wenyuan Gao. (2018) Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis. RSC Advances 8:71, pages 40894-40911.
Crossref
Huiying Liu, Jun Pan, Ye Yang, Xiuming Cui & Yuan Qu. (2018) Production of Minor Ginenosides from Panax notoginseng by Microwave Processing Method and Evaluation of Their Blood-Enriching and Hemostatic Activity. Molecules 23:6, pages 1243.
Crossref
Yi Li, Jinying Lu, Furong Bai, Yanan Xiao, Yiran Guo & Ziming Dong. (2018) Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma. BioMed Research International 2018, pages 1-9.
Crossref